MX2011007754A - Composicion farmaceutica finamente pulverizada. - Google Patents
Composicion farmaceutica finamente pulverizada.Info
- Publication number
- MX2011007754A MX2011007754A MX2011007754A MX2011007754A MX2011007754A MX 2011007754 A MX2011007754 A MX 2011007754A MX 2011007754 A MX2011007754 A MX 2011007754A MX 2011007754 A MX2011007754 A MX 2011007754A MX 2011007754 A MX2011007754 A MX 2011007754A
- Authority
- MX
- Mexico
- Prior art keywords
- finely pulverized
- pharmaceutical composition
- composition
- poorly soluble
- medicinal substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe una composición que contiene una sustancia medicinal pobremente soluble y que tiene absorción oral mejorada y un método para producir la composición. Se describe específicamente una composición finamente pulverizada que contiene una sustancia medicinal pobremente soluble tal como 22ß-metoxiolean-l2-eno--3ß,2 4(4ß)-diol y un agente tensioactivo hidrofílico. También se describe específicamente un método para producir una composición finamente pulverizada, que se caracteriza porque una sustancia medicinal poco soluble y una gente tensioactivo hidrofílico se dispersan primero en un solvente y luego se pulverizan por un homogeneizador de alta presión.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009019771 | 2009-01-30 | ||
PCT/JP2010/051262 WO2010087447A1 (ja) | 2009-01-30 | 2010-01-29 | 微粉砕医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011007754A true MX2011007754A (es) | 2011-08-12 |
Family
ID=42395702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011007754A MX2011007754A (es) | 2009-01-30 | 2010-01-29 | Composicion farmaceutica finamente pulverizada. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110294901A1 (es) |
EP (1) | EP2392354A4 (es) |
JP (1) | JPWO2010087447A1 (es) |
KR (1) | KR20110117145A (es) |
CN (1) | CN102365098A (es) |
AU (1) | AU2010208880A1 (es) |
BR (1) | BRPI1007557A2 (es) |
CA (1) | CA2751236A1 (es) |
MX (1) | MX2011007754A (es) |
RU (1) | RU2011135958A (es) |
SG (1) | SG173158A1 (es) |
WO (1) | WO2010087447A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108567803B (zh) * | 2018-06-29 | 2021-03-02 | 江西济民可信药业有限公司 | 一种金水宝金胶囊的制备方法 |
WO2024058099A1 (ja) * | 2022-09-12 | 2024-03-21 | 住友ファーマ株式会社 | 懸濁用顆粒 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
CN1083483C (zh) * | 1994-09-12 | 2002-04-24 | 生态实验室股份有限公司 | 用于塑料器皿的漂清助剂 |
US5510118A (en) * | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
DK0879824T3 (da) | 1995-07-07 | 2004-08-30 | Meiji Seika Kaisha | Triterpenderivater og middel mod leversygdom |
JP3384967B2 (ja) * | 1997-08-07 | 2003-03-10 | 花王株式会社 | 脂肪酸類からの飽和脂肪酸の低減方法 |
WO2002000196A2 (en) * | 2000-06-28 | 2002-01-03 | Smithkline Beecham P.L.C. | Wet milling process |
US20030224058A1 (en) * | 2002-05-24 | 2003-12-04 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
JP2004099442A (ja) | 2002-09-04 | 2004-04-02 | Nisshin Pharma Inc | 難溶性薬物含有製剤およびその製造方法 |
EP1587499A1 (en) * | 2003-01-31 | 2005-10-26 | Elan Pharma International Limited | Nanoparticulate topiramate formulations |
US8623405B2 (en) * | 2005-01-28 | 2014-01-07 | Takeda Pharmaceutical Company Limited | Finely divided composition containing poorly water soluble substance |
CN101646686A (zh) * | 2007-03-20 | 2010-02-10 | 明治制果株式会社 | 铁过剩症的预防或治疗剂 |
-
2010
- 2010-01-29 US US13/147,011 patent/US20110294901A1/en not_active Abandoned
- 2010-01-29 CA CA2751236A patent/CA2751236A1/en not_active Abandoned
- 2010-01-29 RU RU2011135958/15A patent/RU2011135958A/ru unknown
- 2010-01-29 CN CN2010800148757A patent/CN102365098A/zh active Pending
- 2010-01-29 MX MX2011007754A patent/MX2011007754A/es not_active Application Discontinuation
- 2010-01-29 KR KR1020117018657A patent/KR20110117145A/ko not_active Application Discontinuation
- 2010-01-29 AU AU2010208880A patent/AU2010208880A1/en not_active Abandoned
- 2010-01-29 BR BRPI1007557A patent/BRPI1007557A2/pt not_active IP Right Cessation
- 2010-01-29 JP JP2010548568A patent/JPWO2010087447A1/ja not_active Withdrawn
- 2010-01-29 EP EP10735909A patent/EP2392354A4/en not_active Withdrawn
- 2010-01-29 SG SG2011054244A patent/SG173158A1/en unknown
- 2010-01-29 WO PCT/JP2010/051262 patent/WO2010087447A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010087447A1 (ja) | 2010-08-05 |
CA2751236A1 (en) | 2010-08-05 |
CN102365098A (zh) | 2012-02-29 |
BRPI1007557A2 (pt) | 2016-02-16 |
RU2011135958A (ru) | 2013-03-10 |
EP2392354A1 (en) | 2011-12-07 |
JPWO2010087447A1 (ja) | 2012-08-02 |
AU2010208880A1 (en) | 2011-08-18 |
EP2392354A4 (en) | 2012-08-08 |
SG173158A1 (en) | 2011-08-29 |
US20110294901A1 (en) | 2011-12-01 |
KR20110117145A (ko) | 2011-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008379A (es) | Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones. | |
MX2013007057A (es) | Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos. | |
WO2011047227A3 (en) | Water soluble drug-solubilizer powders and their uses | |
WO2010072958A3 (fr) | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau | |
WO2011082273A3 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
WO2011082270A3 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
WO2011082267A8 (en) | Substituted triazolo-pyrazine compounds | |
WO2007135461A3 (en) | Pharmaceutical compositions comprising implitapide and methods of using same | |
MX2017015879A (es) | Composiciones de hidroxipropil beta-ciclodextrina y metodos. | |
MX2009003065A (es) | Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion. | |
PL2217219T3 (pl) | Podjęzykowa musująca tabletka progesteronu w połączeniu z cyklodekstryną | |
WO2011023367A3 (en) | Bisphosphonate-prodrugs | |
WO2010056039A3 (en) | Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability | |
WO2010065329A3 (en) | Nanoparticles for cancer treatment | |
WO2011082268A3 (en) | Substituted naphthalenyl-pyrimidine compounds | |
PH12015500172A1 (en) | Novel rebamipide prodrugs, preparation method and use thereof | |
MX2011007754A (es) | Composicion farmaceutica finamente pulverizada. | |
WO2010151815A3 (en) | 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
WO2010079433A3 (en) | Pharmaceutical composition comprising melogliptin | |
MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
WO2011087765A3 (en) | Methods of producing stabilized solid pharmaceutical compositions containing morphinans | |
WO2009120844A3 (en) | Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue | |
WO2011031099A3 (en) | Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same | |
ZA201409481B (en) | Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |